All good things take time: the new GBG website has been online since 3 March 2016. We would be pleased to receive your feedback on the new website via the contact form.
The 16th St. Gallen International Breast Cancer Conference 2019 in Vienna is less than seven months away.
Priming the Immune System: Neoadjuvant Durvalumab Plus Chemotherapy May Be Beneficial in Triple-Negative Breast Cancer
The International Scientific Committee and the local organizers invite to another (16th) outstanding «St. Gallen International Breast Cancer Conference» in Vienna, Austria, from 20-23 March 2019!
GeparNuevo Results of primary objective were presented at ASCO 2018: Durvalumab increases the pCR rate in TNBC patients.
ESMO Breast Cancer congress ist taking place in May 2019 in Berlin, Germany.
GBG Forschungs GmbHMartin-Behaim-Str. 12 | 63263 Neu-Isenburg | Fax +49 6102 7480-440
+49 6102 7480-0 | nfGBGd